Funding history
- $400MIPO2026-06-18Source: news.google.com ↗
More Health companies
Recently funded startups in the same category.
Kardigan is a cardiovascular drug startup focused on developing innovative treatments for heart conditions. The company has raised significant funding through both private venture capital and an initial public offering, highlighting its rapid growth and the increasing interest in biotech investments. Its lead drug, danicamtiv, is in late-stage testing for dilated cardiomyopathy, a condition currently lacking approved treatments.
Recently funded startups in the same category.